Stock AEGIR AEGIRBIO AB
Add to a list
To use this feature you must be a member
Log inSign up

News AegirBio AB

Equities

AEGIR

SE0014401121

Market Closed - Nasdaq Stockholm
Other stock markets
 17:00:00 01/07/2024 BST 		5-day change 1st Jan Change
0.425 SEK -11.09% Intraday chart for AegirBio AB -3.95% -63.68%
06-04 Sweden's AegirBio to Change Name to MagnOral MT
05-17 AegirBio AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AegirBio AB has received payment of Tranche 2 of SEK 5.00 million from Atlas Special Opportunities, LLC
AQ
AegirBio receives second milestone payment under RadX NIH
AQ
Sweden's AegirBio to Change Name to MagnOral
MT
AegirBio announces strategic name change to MagnOral AB
AQ
AegirBio AB carries out previously announced directed share issue of 5,175,374 shares corresponding to approximately SEK 2.54 million to Atlas Special Opportunities and calls for payment of Tranche 2
AQ
AegirBio's CEO Marco Witteveen to Attend SalivaDirect's 3rd Annual Conference in Washington, DC, June 5-7, 2024
AQ
AEGIRBIO AB SUCCESSFULLY COMPLETES AN ADDITIONAL MILESTONE OF RADx® TECH PROGRAM
AQ
AegirBio AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
AEGIRBIO study published in Multiple Sclerosis and Related Disorders journal
AQ
AegirBio AB Announces the Findings of Recent Study Published in the Multiple Sclerosis and Related Disorders Journal
CI
AegirBio AB calls for payment of Tranche 1 of SEK 7.50 million and intends to carry out a directed set-off issue of 5,175,374 shares to Atlas Special Opportunities, LLC
AQ
AEGIRBIO Receives Milestone Payment under RadX NIH
AQ
AEGIRBIO AB ADVANCES FURTHER WITH "ACCESSIBILITY" MILESTONE COMPLETION IN RADx® TECH PROGRAM
AQ
AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract
MT
AegirBio AB's subsidiary initiates arbitration against Salofa Oy
AQ
AegirBio Signs Conditional Agreement for SEK45 Million Loan With Atlas
MT
AegirBio Chairman to Resign
MT
AegirBio's chairman has announced his intention to leave the board of directors
AQ
AegirBio AB Announces Intention of Anders Ingvarsson to Resign as Board Member and Chairman
CI
AegirBio enters into a conditional agreement on a MSEK 45 loan facility with Atlas Special Opportunities and an agreement to amend the outstanding convertible bonds, subject to EGM approval
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AEGIR Stock
  4. News AegirBio AB